Literature DB >> 22712057

Coagulation and Fibrinolytic System Protein Profiles in Women with Normal Pregnancies and Pregnancies Complicated by Hypertension.

Sarah A Hale1, Burton Sobel, Anna Benvenuto, Adrienne Schonberg, Gary J Badger, Ira M Bernstein.   

Abstract

OBJECTIVE: The current study longitudinally evaluated concentrations of fibrinogen (Fib), D-Dimer, plasminogen activator type-1 (PAI-1) and tissue type plasminogen activator (T-Pa) before pregnancy and in the first and third trimesters of pregnancy with a focus on the pregnancy transition. STUDY
DESIGN: Twenty healthy, nonsmoking, nulliparous women, aged 29.8 ± 3.0 years, BMI 23.3 ± 3.2 kg/m(2) were studied during menstrual cycle day 8 ± 4 and again in early (11 - 15 wks) and late (31 - 34 wks) pregnancy. Seventeen women had singleton conceptions and delivered at term with uncomplicated pregnancies (CTL) and three women developed complicated hypertension (CH) during pregnancy after the third trimester (late pregnancy) evaluation. Data are means ± SEM, Significance was based on p < 0.05.
RESULTS: Fib was the only protein evaluated that increased in early pregnancy relative to the prepregnancy assessment. D-dimer, PAI-1 and T-Pa increased in the third trimester compared with prepregnant and early pregnant values (p < .001). T-PA was significantly higher during late pregnancy in CH subjects compared with CTL (8.1 ± 0.7 ng/ml vs. 5.0 ± 0.2 ng/ml, p = .02). There were no other differences between groups.
CONCLUSIONS: Increases in fibrinogen are evident in early pregnancy whereas fibrinolysis, perhaps in response to the procoagulant environment of pregnancy, is increased during late pregnancy. Before development of clinically overt hypertension, T-Pa is increased without concomitant changes in other proteins assessed. This is consistent with altered endothelial function with preeclampsia that may contribute to, or reflect, the vasculopathy accompanying this disorder.

Entities:  

Year:  2012        PMID: 22712057      PMCID: PMC3375860          DOI: 10.1016/j.preghy.2012.01.004

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  33 in total

Review 1.  Blood coagulation.

Authors:  Lucy A Norris
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-06       Impact factor: 5.237

2.  Increased circulating thrombomodulin levels in pre-eclampsia.

Authors:  Luci M Dusse; Maria G Carvalho; Kathryn Getliffe; David Voegeli; Alan J Cooper; Bashir A Lwaleed
Journal:  Clin Chim Acta       Date:  2007-09-05       Impact factor: 3.786

3.  A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives.

Authors:  I S Menon; M Peberdy; G H Rannie; D Weightman; H A Dewar
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-08

4.  Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency.

Authors:  P W Howie; C R Prentice; G P McNicol
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-11

5.  Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.

Authors:  J R Higgins; J J Walshe; M R Darling; L Norris; J Bonnar
Journal:  Am J Obstet Gynecol       Date:  1998-08       Impact factor: 8.661

6.  Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.

Authors:  Marianne Coolman; Christianne J M de Groot; Eric A P Steegers; Anneke Geurts-Moespot; Chris M G Thomas; Régine P M Steegers-Theunissen; Fred C G J Sweep
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-04-11       Impact factor: 2.435

Review 7.  The 'PAI-1 paradox' in vascular remodeling.

Authors:  Isabel Diebold; Damir Kraicun; Steve Bonello; Agnes Görlach
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

8.  Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks.

Authors:  B J Hunt; H Missfelder-Lobos; M Parra-Cordero; O Fletcher; K Parmar; E Lefkou; C C Lees
Journal:  J Thromb Haemost       Date:  2009-03-13       Impact factor: 5.824

9.  Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.

Authors:  A Halligan; J Bonnar; B Sheppard; M Darling; J Walshe
Journal:  Br J Obstet Gynaecol       Date:  1994-06

10.  Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.

Authors:  Y Cadroy; H Grandjean; J Pichon; R Desprats; A Berrebi; A Fournié; B Boneu
Journal:  Br J Obstet Gynaecol       Date:  1993-05
View more
  5 in total

1.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

2.  Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Authors:  Bérangère S Joly; Bénédicte Sudrié-Arnaud; Virginie Barbay; Jeanne-Yvonne Borg; Véronique Le Cam Duchez
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

3.  First-Trimester Inflammatory Markers for Risk Evaluation of Pregnancy Hypertension.

Authors:  Karuna Sharma; Ritu Singh; Manisha Kumar; Usha Gupta; Vishwajeet Rohil; Jayashree Bhattacharjee
Journal:  J Obstet Gynaecol India       Date:  2017-04-19

4.  Variations of plasma D-dimer level at various points of normal pregnancy and its trends in complicated pregnancies: A retrospective observational cohort study.

Authors:  Uttam Baboolall; Ying Zha; Xun Gong; Dong Rui Deng; Fuyuan Qiao; Haiyi Liu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Fibrinolytic Changes in Women with Preeclampsia.

Authors:  Anne Cathrine Godtfredsen; Johannes Jakobsen Sidelmann; Britta Blume Dolleris; Jan Stener Jørgensen; Emma Kathrine Jungjohan Johansen; Melissa Fernard Bøg Pedersen; Yaseelan Palarasah; Jørgen Brodersen Gram
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.